BNR
Burning Rock Biotech Ltd
15.20$
+0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.2% | -13.2% | -32.0% | -30.1% | -23.5% | 15.1% | -17.7% | -29.9% | 12.5% | 18.5% | -27.1% | -16.6% | -2.4% | |
| 103.0% | 108.6% | 104.6% | – | – | – | 39.2% | – | – | – | 20.2% | – | – | |
| 57.5% | 58.9% | 55.2% | 50.3% | 7.9% | – | 3.4% | 1.6% | – | – | 1.7% | – | – | |
| -3.4% | -3.6% | -3.5% | – | – | – | -31.5% | – | – | – | -55.0% | – | – | |
| 6.4% | 6.7% | 6.5% | 0.0% | 0.0% | 0.0% | 4.1% | 0.0% | 0.0% | 0.0% | 4.9% | 0.0% | 1.1% | |
| -1.6% | -0.3% | -1.9% | -0.2% | -0.8% | – | -1.2% | 0.1% | -2.1% | – | -0.3% | -1.8% | – | |
| -5.5% | -5.8% | -5.6% | – | – | – | -0.1% | – | – | – | – | – | – | |
| -36.0% | -1.6% | -1.5% | – | 0.0% | – | -0.1% | 1.3% | – | – | -0.1% | -0.1% | – | |
| -75.7% | -17.8% | -33.9% | -29.2% | -27.1% | 19.0% | -18.6% | -28.5% | 9.1% | 11.3% | -30.0% | -22.0% | -7.2% | |
| -37.2% | -19.9% | -32.0% | -30.1% | -23.5% | 10.4% | -17.7% | -29.9% | 12.5% | 14.3% | -27.1% | -16.6% | -3.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.